Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,230 | -11,136 | -13,583 | -23,845 | -20,288 |
| Depreciation Amortization | 1,309 | 581 | 621 | 669 | 733 |
| Accounts receivable | -217 | -228 | 255 | 746 | 228 |
| Accounts payable and accrued liabilities | 524 | -1,048 | 734 | 491 | 139 |
| Other Working Capital | 3,997 | -2,940 | 2,864 | 1,711 | 28 |
| Other Operating Activity | 354 | 2,080 | -2,837 | 641 | 3,425 |
| Operating Cash Flow | $-15,263 | $-12,691 | $-11,946 | $-19,587 | $-15,735 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,341 | -568 | -803 | -924 | -2,396 |
| Net Acquisitions | -5,185 | N/A | N/A | N/A | -225 |
| Other Investing Activity | 0 | 0 | -50 | 0 | 13 |
| Investing Cash Flow | $-7,526 | $-568 | $-853 | $-924 | $-2,608 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,673 | N/A | N/A | N/A | N/A |
| Debt Repayment | -28 | N/A | N/A | N/A | -25 |
| Common Stock Issued | 8,750 | 19,237 | 12,000 | 0 | 27,930 |
| Other Financing Activity | -837 | -1,361 | -1,077 | 0 | -3,738 |
| Financing Cash Flow | $18,558 | $17,876 | $10,923 | $0 | $24,167 |
| Beginning Cash Position | 6,260 | 1,643 | 3,519 | 24,030 | 18,206 |
| End Cash Position | 2,029 | 6,260 | 1,643 | 3,519 | 24,030 |
| Net Cash Flow | $-4,231 | $4,617 | $-1,876 | $-20,511 | $5,824 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,263 | -12,691 | -11,946 | -19,587 | -15,735 |
| Capital Expenditure | -2,341 | -568 | -803 | -924 | -2,396 |
| Free Cash Flow | -17,604 | -13,259 | -12,749 | -20,511 | -18,131 |